Expression and Preparation of Recombinant Reelin and ADAMTS-3 Proteins.


Journal

Methods in molecular biology (Clifton, N.J.)
ISSN: 1940-6029
Titre abrégé: Methods Mol Biol
Pays: United States
ID NLM: 9214969

Informations de publication

Date de publication:
2020
Historique:
entrez: 30 8 2019
pubmed: 30 8 2019
medline: 11 4 2020
Statut: ppublish

Résumé

Reelin is a large secreted protein that is essential for the brain development and function. Reelin is negatively regulated by the specific cleavage by a disintegrin and metalloproteinase with thrombospondin type 1 motifs 3 (ADAMTS-3) which is also secreted from neurons. It is likely that there are other proteases that can cleave Reelin. This chapter describes the protocol for expression and handling of recombinant Reelin and ADAMTS-3 proteins to facilitate investigation of these proteins.

Identifiants

pubmed: 31463905
doi: 10.1007/978-1-4939-9698-8_8
doi:

Substances chimiques

Cell Adhesion Molecules, Neuronal 0
Extracellular Matrix Proteins 0
Nerve Tissue Proteins 0
Recombinant Proteins 0
Reelin Protein 0
RELN protein, human EC 3.4.21.-
Serine Endopeptidases EC 3.4.21.-
ADAMTS Proteins EC 3.4.24.-
ADAMTS3 protein, human EC 3.4.24.-
Procollagen N-Endopeptidase EC 3.4.24.14

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

93-104

Auteurs

Takao Kohno (T)

Department of Biomedical Science, Graduate School of Pharmaceutical Sciences, Nagoya City University, Nagoya, Aichi, Japan.

Himari Ogino (H)

Department of Biomedical Science, Graduate School of Pharmaceutical Sciences, Nagoya City University, Nagoya, Aichi, Japan.

Yuko Yamakage (Y)

Department of Biomedical Science, Graduate School of Pharmaceutical Sciences, Nagoya City University, Nagoya, Aichi, Japan.

Mitsuharu Hattori (M)

Department of Biomedical Science, Graduate School of Pharmaceutical Sciences, Nagoya City University, Nagoya, Aichi, Japan. mhattori@phar.nagoya-cu.ac.jp.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH